| Literature DB >> 30655681 |
Yiqi Fu1, Min Xu2, Yanchao Liu2, Ang Li3, Jianying Zhou1.
Abstract
BACKGROUND: Capsular serotype K2 Klebsiella pneumoniae of sequence type (ST) 65 has been recognized as a hypervirulent clone. Simultaneous presence of different bla CTX-M genes has never been reported in this clone. In the present study, the genetic characteristics and virulence phenotype of a CTX-M-3 and CTX-M-14 coproducing ST65 K. pneumoniae human isolate, KP_06, that caused an intracranial infection, are evaluated.Entities:
Keywords: Klebsiella pneumoniae; ST65; blaCTX-M; comparative genome; serotype K2; virulence factor
Year: 2019 PMID: 30655681 PMCID: PMC6322562 DOI: 10.2147/IDR.S187289
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1The detection of virulence potential of the KP_06.
Notes: (A) Biofilm biomass expressed as crystal violet OD (OD570 nm). Data are expressed as mean ± SD (error bars) of at least three independent experiments for each strain. (B) Survival of each strain was assessed by enumerating viable counts at 0, 1, 2, and 3 hours of incubation in the pooled human serum at 37°C. Data are presented as mean ± SD (n=3 for each strain). (C) The effect of 1×106 CFU of each K. pneumoniae strain on the survival of G. mellonella, whereas other doses of each K. pneumoniae strain induce dose-dependent lethality are shown in Figure S2. KP_07 is a ST23:K1 strain that harbored a ~220 kbp virulence plasmid and is used as positive control. KP_36 is a blaKPC-2-producing ST11 strain that did not harbor virulence plasmid and is used as a negative control in these studies.
Abbreviations: CFU, colony-forming unit; G. mellonella, Galleria mellonella; K. pneumoniae, Klebsiella pneumoniae; ST, sequence type.
General genomic features of the KP_06 isolate
| Elements and characteristics | Value |
|---|---|
|
| |
| Genome size (bp) | 5,655,975 |
| N50 (bp) | 259,669 |
| DNA coding region (%) | 86.7 |
| DNA GC content (%) | 56.9 |
| Contig number | 65 |
| Total genes | 5,390 |
| sRNA genes | 46 |
| tRNA genes | 81 |
| Plasmids | 2 |
| Protein-coding genes | 5,338 |
| Genes assigned to COGs | 4,443 |
| Genes assigned to Pfam domains | 3,875 |
Abbreviation: CO, clusters of orthologous groups.
General distribution of virulence and resistance genes of KP_06 and five other serotype K2 strains that were compared
| Features of virulence and resistance | KP_06 | RJF293 | U25 | KP52.145 | hvKP1 | NUHL24835 |
|---|---|---|---|---|---|---|
|
| ||||||
| HM phenotype | Positive | Positive | Positive | Positive | Positive | Positive |
| Capsule serotype | K2 | K2 | K2 | K2 | K2 | K2 |
| Sequence types | ST65 | ST374 | ST14 | ST66 | ST86 | ST14 |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| Enterobactin ( | + | + | + | + | + | + |
| Aerobactin ( | + | + | + | + | − | − |
| Aerobactin receptor ( | + | + | + | + | + | + |
| Yersiniabactin ( | + | + | + | + | + | + |
| Salmochelin ( | + | + | + | + | − | − |
| Salmochelin receptor ( | + | + | + | + | + | + |
| Type 3 fimbrial genes ( | + | + | + | + | + | + |
| Type 1 fimbrial genes ( | + | + | + | + | + | + |
| Colibactin ( | + | + | − | − | − | − |
| − | + | − | + | + | + | |
| β-Lactamases | − | |||||
| Aminoglycoside-resistant genes | − | − | − | |||
| Fluoroquinolone-resistant genes | − | − | − | − | − | |
| Other resistance genes | ||||||
Notes: “+” indicates the presence of the corresponding gene. “−” indicates the absence of the corresponding gene.
Abbreviation: HM, hypermucoviscosity.
Figure 2Genomic sequence comparative analysis of KP_06 and five HM K2-serotype K. pneumoniae strains.
Notes: (A) Whole-genome sequences’ comparison of the strains. The circles from inside to outside indicate GC content of KP_06, GC skew of KP_06, and the K2-serotype K. pneumoniae strains 52.125, hvKP1, NUHL24835, RJF293, U25, and KP_06. The white and colored regions of the rings indicate absent and present, respectively. (B) Network graph shows shared orthologies and unique orthologies among the strains. Blue nodes: the name of K. pneumoniae strains; green nodes: the number of unique orthologies of the corresponding strain; the gray nodes: the number of shared orthologies among strains.
Abbreviations: HM, hypermucoviscosity; K. pneumoniae, Klebsiella pneumoniae.
The distribution of COGs’ functional catalogs of the orthologies for the six K. pneumoniae strains
| COGs’ categories | Shared orthologies | Unique orthologies
| |||||
|---|---|---|---|---|---|---|---|
| KP_06 | RJF293 | U25 | 52.145 | hvKP1 | NUHL24835 | ||
|
| |||||||
| Nucleotide transport and metabolism (F) | 49 | 0 | 0 | 0 | 0 | 0 | 0 |
| Function unknown (S) | 52 | 2 | 0 | 0 | 0 | 1 | 0 |
| Signal transduction mechanisms (T) | 65 | 0 | 1 | 0 | 0 | 0 | 0 |
| Cell motility (N) | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transcription (K) | 53 | 0 | 0 | 1 | 0 | 0 | 0 |
| Amino acid transport and metabolism (E) | 172 | 0 | 0 | 0 | 0 | 1 | 1 |
| Defense mechanisms (V) | 21 | 1 | 0 | 1 | 1 | 1 | 1 |
| Cytoskeleton (Z) | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Secondary metabolites biosynthesis, transport and catabolism (Q) | 44 | 0 | 1 | 0 | 0 | 1 | 0 |
| Cell wall/membrane/envelope biogenesis (M) | 112 | 1 | 0 | 0 | 0 | 1 | 2 |
| Energy production and conversion (C) | 112 | 0 | 0 | 0 | 0 | 0 | 0 |
| Replication, recombination and repair (L) | 69 | 0 | 0 | 1 | 0 | 0 | 2 |
| Post-translational modification, protein turnover, and chaperones (O) | 58 | 0 | 0 | 0 | 0 | 1 | 1 |
| Translation, ribosomal structure, and biogenesis (J) | 100 | 0 | 0 | 0 | 0 | 1 | 1 |
| Extracellular structures (W) | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mobilome: prophages, transposons (X) | 5 | 0 | 0 | 2 | 2 | 0 | 1 |
| Inorganic ion transport and metabolism (P) | 124 | 0 | 0 | 0 | 1 | 1 | 0 |
| Chromatin structure and dynamics (B) | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coenzyme transport and metabolism (H) | 94 | 1 | 0 | 1 | 1 | 0 | 0 |
| Cell cycle control, cell division, and chromosome partitioning (D) | 24 | 1 | 0 | 0 | 0 | 0 | 0 |
| General function prediction only (R) | 116 | 0 | 0 | 2 | 0 | 0 | 0 |
| Lipid transport and metabolism (I) | 53 | 1 | 0 | 0 | 0 | 0 | 0 |
| Carbohydrate transport and metabolism (G) | 140 | 1 | 0 | 0 | 0 | 0 | 0 |
| Intracellular trafficking, secretion, and vesicular transport (U) | 30 | 0 | 0 | 0 | 1 | 1 | 1 |
| Not assigned (−) | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Abbreviations: COGs, clusters of orthologous groups; K. pneumoniae, Klebsiella pneumoniae.
Antibiotics susceptibility profile of the KP_06 strain.
| Antibiotics | MIC (μg/mL) | Interpretation |
|---|---|---|
| Ampicillin | ≥32 | R |
| Amikacin | ≤2 | S |
| Aztreonam | 16 | R |
| Ciprofloxacin | 1 | S |
| Ceftriaxone | ≥64 | R |
| Gentamicin, CN10 | ≤1 | S |
| Levofloxacin | 1 | S |
| Ceftazidime | ≥64 | R |
| Cefepime | ≥32 | R |
| Ampicillin–sulbactam | ≥32 | R |
| Piperacillin–tazobactam | 8 | R |
| Ertapenem | ≤0.12 | S |
| Imipenem | 0.5 | S |
| Cefotetan | ≤4 | S |
| Trimethoprim–sulfamethoxazole | ≤20 | S |
| Tigecycline | 1 | S |
Abbreviations: MIC, minimum inhibitory concentration; R, resistant; S, susceptible.
Pairwise SNP comparison between KP_06 isolate and five other HM serotype K2 strains
| Strain ID | KP_06 | 52.145 | NUHL24835 | RJF293 | U25 | hvKP1 |
|---|---|---|---|---|---|---|
| KP_06 | 0 | 20,386 | 21,551 | 21,578 | 21,550 | 21,096 |
| 52.145 | 20,386 | 0 | 21,316 | 21,281 | 21,316 | 20,919 |
| NUHL24835 | 21,551 | 21,316 | 0 | 19,447 | 597 | 20,382 |
| RJF293 | 21,578 | 21,281 | 19,447 | 0 | 19,465 | 20,434 |
| U25 | 21,550 | 21,316 | 597 | 19,465 | 0 | 20,374 |
| hvKP1 | 21,096 | 20,919 | 20,382 | 20,434 | 20,374 | 0 |
| NTUH-K2044 | 20,286 | 19,950 | 19,218 | 19,196 | 19,113 | 19,720 |
Notes: The complete genomic sequence of NTUH-K2044 was used as the reference. The numbers depicted differences in SNPs exhibited by each strain pair.
Abbreviations: HM, hypermucoviscosity; hvKP1, hypervirulent Klebsiella pneumoniae; SNPs, single-nucleotide polymorphisms.
Putative virulence genes detected in the genome of KP_06 strain and five other serotype K2 strains
| Virulence genes | ||||||
|---|---|---|---|---|---|---|
| KP_06 | RJF293 | U25 | 52.145 | hvKP1 | NUHL24835 | |
|
| ||||||
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| + | + | − | − | − | − | |
| − | + | − | + | + | + | |
| − | + | − | + | + | + | |
| − | + | − | + | + | + | |
| + | − | − | + | − | − | |
| + | − | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | − | − | |
| − | − | + | − | − | − | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | + | + | + | |
| − | − | − | + | − | − | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | − | − | − | − | − | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | − | + | − | − | − | |
| − | − | − | + | − | − | |
| + | + | + | − | + | + | |
| + | + | + | − | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | − | + | + | − | − | |
| + | + | + | + | + | + | |
| − | − | + | − | − | − | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| + | + | + | + | + | + | |
| Plasmid | ||||||
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | + | + | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | − | − | |
| + | + | + | + | + | + | |
Notes: “+” indicates the presence of the corresponding gene. “−” indicates the absence of the corresponding gene.
Abbreviations: hvKP1, hypervirulent K. pneumoniae; K. pneumoniae, Klebsiella pneumoniae.